When colorectal cancer spreads outside the colon or rectum, cancer cells are often found in nearby lymph nodes. If cancer cells have reached these nodes, they may also have spread to other lymph nodes, the liver, or other organs.

Hodgkin's Disease - A cancer of the immune system that is marked by the presence of a type of cell called the Reed Sternberg cell. Symptoms include the painless enlarged lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats. Also called Hodgkin's lymphoma.

The term comes from a Greek word meaning "fleshy growth." Bone tumors (osteosarcomas) are also called sarcomas, but are in a separate category because they have different clinical and microscopic characteristics and are treated differently. Osteogenic sarcoma or osteosarcoma is one of the most common childhood bone cancers. Soft tissue sarcomas are more common in adults than in children. In all, sarcomas constitute less than 1% of all cancers. Its treatment is made more difficult with the existence of more than 70 varieties. Gastrointestinal stromal tumor (GIST) is the most common form of sarcoma, with approximately 3000-3500 cases per year in the United States.

is a term used to describe a group of chronic conditions affecting body movements and muscle coordination. It is caused by damage to one or more specific areas of the brain, usually occurring during fetal development, or during infancy. It can also occur before, during or shortly following birth. "Cerebral" refers to the brain and "Palsy" to a disorder of movement or posture.

Antitrust: control of collusion and other anti-competitive practices which has an effect on the EU (or, since 1994, the European Economic Area). This is covered under Articles 81 and 82 EC respectively.

Mergers: control of proposed mergers, acquisitions and joint ventures involving companies which have a certain, defined amount of turnover in the EU/EEA. This is governed by the Council Regulation 139/2004 EC (the Merger Regulation).

State aid: control of direct and indirect aid given by EU Member States to companies. Covered under Article 87 EC (ex Article 92).